Cancer Management and Research (Nov 2022)

RNA Modifications Meet Tumors

  • Yang Z,
  • Zhang S,
  • Xia T,
  • Fan Y,
  • Shan Y,
  • Zhang K,
  • Xiong J,
  • Gu M,
  • You B

Journal volume & issue
Vol. Volume 14
pp. 3223 – 3243

Abstract

Read online

Zhiyuan Yang,1,2,* Siyu Zhang,1,2,* Tian Xia,1,2,* Yue Fan,1,2 Ying Shan,1,2 Kaiwen Zhang,1,2 Jiayan Xiong,1,2 Miao Gu,1,2 Bo You1,2 1Department of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, People’s Republic of China; 2Institute of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bo You; Miao Gu, Email [email protected]; [email protected]: RNA modifications occur through the whole process of gene expression regulation, including transcription, translation, and post-translational processes. They are closely associated with gene expression, RNA stability, and cell cycle. RNA modifications in tumor cells play a vital role in tumor development and metastasis, changes in the tumor microenvironment, drug resistance in tumors, construction of tumor cell-cell “internet”, etc. Several types of RNA modifications have been identified to date and have various effects on the biological characteristics of different tumors. In this review, we discussed the function of RNA modifications, including N6-methyladenine (m6A), 5-methylcytosine (m5C), N7-methyladenosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), and adenosine-to-inosine (A-to-I), in the microenvironment and therapy of solid and liquid tumors.Keywords: tumor, RNA modification, non-coding RNA, tumor microenvironment, tumor therapy

Keywords